Genetic polymorphisms in SCN2A are not associated with epilepsy risk and AEDs response: evidence from a meta-analysis

[1] Fischer R(2014)ILAE official report: a practical clinical definition of epilepsy Epilepsia 55 475-482

[2] Lakhan WA(2009)Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population Br J Clin Pharmacol 68 214-220

[3] Catterall AL(2005)International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels Pharmacol Rev 57 397-409

[4] Goldin SG(2018)Progress in understanding and treating SCN2A-mediated disorders Trends Neurosci 41 442-456

[5] Waxman SJ(2008)Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression Pharmacogenet Genomics 18 989-998

[6] Sanders AJ(2014)Associations between the C3435T polymorphism of the ABCB1 gene and drug resistance in epilepsy: a meta-analysis Int J Clin Exp Med 7 3924-3932

[7] Campbell P(2015)SCN2A encephalopathy: a major cause of epilepsy of infancy with migrating focal seizures Neurology 85 958-966

[8] Kwan WP(2016)Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation Psychiatr Genet 26 60-65

[9] Lv RF(2017)Opposing effects on NaV1.2 function underlie differences between SCN2A variants observed in individuals with autism spectrum disorder or infantile seizures Biol Psychiatry 82 224-232

[10] Han ZR(2010)SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain Neurology 75 1454-1458

[1] Fischer R(2014)ILAE official report: a practical clinical definition of epilepsy Epilepsia 55 475-482

[2] Lakhan WA(2009)Differential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian population Br J Clin Pharmacol 68 214-220

[3] Catterall AL(2005)International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels Pharmacol Rev 57 397-409

[4] Goldin SG(2018)Progress in understanding and treating SCN2A-mediated disorders Trends Neurosci 41 442-456

[5] Waxman SJ(2008)Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression Pharmacogenet Genomics 18 989-998

[6] Sanders AJ(2014)Associations between the C3435T polymorphism of the ABCB1 gene and drug resistance in epilepsy: a meta-analysis Int J Clin Exp Med 7 3924-3932

[7] Campbell P(2015)SCN2A encephalopathy: a major cause of epilepsy of infancy with migrating focal seizures Neurology 85 958-966

[8] Kwan WP(2016)Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation Psychiatr Genet 26 60-65

[9] Lv RF(2017)Opposing effects on NaV1.2 function underlie differences between SCN2A variants observed in individuals with autism spectrum disorder or infantile seizures Biol Psychiatry 82 224-232

[10] Han ZR(2010)SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain Neurology 75 1454-1458